Header Logo

Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model.

Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model. J Trauma Acute Care Surg. 2018 05; 84(5):795-801.

View in: PubMed